Back to Authors

Vizkelety, Tamas

A5078335978 | I2948539688

Mayo Clinic

AbbVie (United States)

Citations 1

Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study

Blood Advances | January 8, 2024 | Volume: 8 | Issue: 4 | Pages: 842-845

10.1182/bloodadvances.2023012248 | PMID 38190628